Stay updated on ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial.
Sign up to get notified when there's something new on the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page.

Latest updates to the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page
- Check7 days agoChange DetectedA new Revision: v3.6.6 was added and the previous Revision: v3.6.5 was removed, reflecting an update to the page's version metadata.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe revision label in the page footer was updated from v3.6.4 to v3.6.5, signaling an updated build of the page without altering study details or navigation.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page revision has been updated from v3.6.3 to v3.6.4, indicating a small backend or content management system update rather than a change to the study information or visible layout.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3. This is a minor metadata update to the study record rather than a substantive change to the content.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, indicating a newer version of the page. This update reflects a minor maintenance or content update without altering the study details presented.SummaryDifference0.1%

- Check85 days agoChange DetectedAdded recruitment status notice 'No longer looking for participants' and new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) along with an updated Intervention/Treatment heading. The old Intervention / Treatment label and the previous revision tag (v3.5.5) were removed, and the revision tag now shows v3.6.0.SummaryDifference0.4%

Stay in the know with updates to ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page.